Aphrocallistes Vastus Lectinを発現する腫瘍性ワクチンウイルスは,ACSS2/TFEB媒介によるオートファギーと脂質蓄積を通じて肝細胞癌の代謝を調節する
Qiang Wang1, Simeng Zhou1, Yin Wang1
1College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Marine drugs
|August 27, 2025
まとめ
肝臓がん (HCC) に対する腫瘍解毒ウイルス治療は,がん細胞の代謝をターゲットにすることで強化することができます. 新しいウイルス (oncoVV-AVL) は,ACSS2/TFEB経路を利用して,脂質の蓄積を引き起こし,グルコースの使用を抑制し,それによって腫瘍の成長を抑制します.
科学分野:
- 腫瘍学
- ウイルス学
- メタボリック・エンジニアリング
背景:
- 肝細胞癌 (HCC) は,代謝適応性と治療に対する耐性により,治療上の大きな課題を提示しています.
- 腫瘍解毒ウイルス (OV) は,選択的に癌細胞を破壊し,抗腫瘍免疫を刺激することで有望であることが示されていますが,癌との代謝相互作用は完全に理解されていません.
研究 の 目的:
- Aphrocallistes vastus lectinを発現する新型腫瘍性ウイルス (oncoVV-AVL) を設計する.
- ACSS2/TFEB軸を中心に,oncoVV-AVLとHCC細胞の代謝相互作用を調査する.
- HCCモデルにおける oncoVV-AVLの治療の可能性を評価する.
主な方法:
- Aphrocallistes vastus lectin (AVL) を発現させるためのオンコロチスワクチンウイルス (oncoVV) のエンジニアリング.
- 細胞代謝のインビトロ分析,グルコースの吸収,乳酸の生成,脂質の蓄積,および自己死性のマーカーを含む.
- 腫瘍の成長,全身代謝の変化,および自己死性の活性化を評価するためにHCCモデルでのin vivo研究.
- アセチル-コア合成酵素2 (ACSS2) の薬理学的阻害は,その役割を検証する.
主要な成果:
- OncoVV- AVLは,HCC細胞における有意な脂質蓄積 (FASN,ACC1アップレギュレーション) を誘導し,グルコース代謝を抑制した.
- ウイルスはオートファギーを促進し,ACSS2を上位に調節し,その核転移とTFEBとの相互作用を促進しました.
- oncoVV- AVLによって誘発された代謝効果は逆転した.
- in vivoでは,oncoVV- AVLは腫瘍の成長を抑制し,全身のグルコースレベルを低下させ,トリグリセリドレベルを上昇させ,代謝の再プログラムを示した.
結論:
- oncoVV-AVLは,ACSS2/TFEBの代謝軸を利用してHCCを効果的に標的にします.
- ACSS2は,HCCの腫瘍性ウイルス治療における代謝チェックポイントとして重要な役割を果たします.
- ACSS2を標的とする代謝調節剤と腫瘍解毒性ウイルス治療を組み合わせることは,HCC治療の有望な戦略です.
さらに関連する動画
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.0K
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
6.5K
関連する概念動画
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Mechanisms of Retrovirus-induced Cancers
5.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
